Were Michelle D. Greene’s CAH share sales under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not affirmatively marked, so these CAH share sales are not identified as occurring under an affirmed Rule 10b5-1 trading plan. The footnotes describe pricing details but do not mention any trading plan arrangement.

Cardinal Health CIO sells 11,650 shares at $234–237

Q: What insider transaction did CAH executive Michelle D. Greene report on this Form 4?

Michelle D. Greene, Chief Information Officer of CAH, reported selling 11,650 common shares on August 18, 2026. The sales occurred in multiple open-market or private transactions, disclosed in four tranches with separate weighted average prices and detailed price ranges in the footnotes.

Q: At what prices did Michelle D. Greene sell Cardinal Health (CAH) shares?

Michelle D. Greene sold Cardinal Health CAH shares at weighted average prices of $234.57, $235.68, $236.31, and $237.25. The footnotes state each average covers multiple trades within narrower price ranges from $234.07 up to $237.32 per share.

Q: How many Cardinal Health (CAH) shares did Michelle D. Greene sell in each tranche?

On August 18, 2026, Michelle D. Greene sold 2,500, 4,952, 3,512, and 686 Cardinal Health CAH common shares in four separate transactions. All were reported as sales of non-derivative common shares held directly by the reporting person.

Q: What type of security did Michelle D. Greene sell in Cardinal Health (CAH)?

Michelle D. Greene sold non-derivative Common Shares of Cardinal Health CAH. All four reported transactions involved direct ownership of common shares, with no derivative securities, options, or conversions disclosed in this Form 4 filing for the August 18, 2026 trades.

CARDINAL HEALTH INC (CAH) reported that Chief Information Officer Michelle D. Greene sold a total of 11,650 common shares on August 18, 2026, in multiple open-market or private transactions.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

CARDINAL HEALTH INC (CAH) reported that Chief Information Officer Michelle D. Greene sold a total of 11,650 common shares on August 18, 2026, in multiple open-market or private transactions. The sales were executed in four tranches at weighted average prices of $234.57, $235.68, $236.31, and $237.25 per share, with each weighted average representing numerous individual trades within specified price ranges as disclosed in the footnotes.

Insider Trade Summary

Net Seller: 11,650 shares

Net Sell 4 txns

Insider Greene Michelle D.

Role Chief Information Officer

Sold 11,650 shs ($2.75M)

Type	Security	Shares	Price	Value
Sale	Common Shares ^F1	2,500	$234.57	$586K
Sale	Common Shares ^F2	4,952	$235.68	$1.17M
Sale	Common Shares ^F3	3,512	$236.31	$830K
Sale	Common Shares ^F4	686	$237.25	$163K

Holdings After Transaction: Common Shares — 10,330 shares (Direct)

Footnotes (4)

F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, 3, and 4 to this Form 4.
F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.08 to $236.07, inclusive.
F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.08 to $236.96, inclusive.
F4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.125 to $237.32, inclusive.

Key Figures

Shares sold tranche 1: 2,500 shares at $234.57 per share Shares sold tranche 2: 4,952 shares at $235.68 per share Shares sold tranche 3: 3,512 shares at $236.31 per share +4 more

7 metrics

Shares sold tranche 1 2,500 shares at $234.57 per share Non-derivative common share sale on 2026-08-18

Shares sold tranche 2 4,952 shares at $235.68 per share Non-derivative common share sale on 2026-08-18

Shares sold tranche 3 3,512 shares at $236.31 per share Non-derivative common share sale on 2026-08-18

Shares sold tranche 4 686 shares at $237.25 per share Non-derivative common share sale on 2026-08-18

Total shares sold 11,650 shares Aggregate of four sale transactions on 2026-08-18

Price range footnote F1 $234.07 to $235.06 per share Price range for tranche with weighted average $234.57

Highest disclosed price range $237.125 to $237.32 per share Price range for tranche with weighted average $237.25

Key Terms

weighted average price, open market or private transaction, non-derivative

3 terms

weighted average price financial

"The price reported in column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

non-derivative financial

"transaction_type": "non-derivative""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CAH executive Michelle D. Greene report on this Form 4?

Michelle D. Greene, Chief Information Officer of CAH, reported selling 11,650 common shares on August 18, 2026. The sales occurred in multiple open-market or private transactions, disclosed in four tranches with separate weighted average prices and detailed price ranges in the footnotes.

At what prices did Michelle D. Greene sell Cardinal Health (CAH) shares?

Michelle D. Greene sold Cardinal Health CAH shares at weighted average prices of $234.57, $235.68, $236.31, and $237.25. The footnotes state each average covers multiple trades within narrower price ranges from $234.07 up to $237.32 per share.

How many Cardinal Health (CAH) shares did Michelle D. Greene sell in each tranche?

On August 18, 2026, Michelle D. Greene sold 2,500, 4,952, 3,512, and 686 Cardinal Health CAH common shares in four separate transactions. All were reported as sales of non-derivative common shares held directly by the reporting person.

What type of security did Michelle D. Greene sell in Cardinal Health (CAH)?

Michelle D. Greene sold non-derivative Common Shares of Cardinal Health CAH. All four reported transactions involved direct ownership of common shares, with no derivative securities, options, or conversions disclosed in this Form 4 filing for the August 18, 2026 trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/20/2026 - 07:28 AM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Greene Michelle D.

(Last)

(First)

(Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN

OHIO

43017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Information Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	08/18/2026		S		2,500	D	$234.57⁽¹⁾	19,480	D
Common Shares	08/18/2026		S		4,952	D	$235.68⁽²⁾	14,528	D
Common Shares	08/18/2026		S		3,512	D	$236.31⁽³⁾	11,016	D
Common Shares	08/18/2026		S		686	D	$237.25⁽⁴⁾	10,330	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, 3, and 4 to this Form 4.

2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.08 to $236.07, inclusive.

3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.08 to $236.96, inclusive.

4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.125 to $237.32, inclusive.

Remarks:

	/s/ Amanda S. Pashi, Attorney-in-fact	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR